From: An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes
Cytokine | Method | PSP/CBS | MSA | PD | Controls | p-value |
---|---|---|---|---|---|---|
ICAM-1 | Array | 0.98 ± 0.25 | 0.47 ± 0.09 | 0.62 ± 0.15 | 1.00 ± 0.28 | <0.05a |
(ICAM1) | FCM | 1.25 ± 0.85 | 0.75 ± 0.29 | 0.86 ± 0.43 | 1.00 ± 0.73 | nsb |
IL-2 Ra | Array | 2.14 ± 0.47 | 1.87 ± 0.10 | 1.24 ± 0.06 | 1.00 ± 0.14 | <0.05a |
(IL2RA) | ELISA | 1.44 ± 0.76 | 1.24 ± 0.61 | 1.15 ± 0.55 | 1.00 ± 0.29 | nsb |
Leptin | Array | 1.93 ± 0.11 | 1.13 ± 0.23 | 1.91 ± 0.46 | 1.00 ± 0.11 | <0.05a |
(LEP) | FCM | 2.95 ± 4.89 | 1.42 ± 1.15 | 1.86 ± 1.88 | 1.00 ± 0.89 | nsb |
MCP-4 | Array | 7.18 ± 0.85 | 2.16 ± 1.39 | 1.71 ± 0.80 | 1.00 ± 0.76 | <0.05a |
(CCL13) | ELISA | 1.15 ± 0.32 | 0.91 ± 0.37 | 1.02 ± 0.32 | 1.00 ± 0.42 | nsb |
PDGF-BB | Array | 1.87 ± 0.50 | 1.34 ± 0.18 | 1.34 ± 0.22 | 1.00 ± 0.44 | <0.05a |
(PDGFB) | FCM | 1.42 ± 0.30 | 1.32 ± 0.39 | 1.11 ± 0.28 | 1.00 ± 0.33 | <0.05b |
Prolactin | Array | 4.17 ± 1.74 | 1.03 ± 0.15 | 0.99 ± 0.08 | 1.00 ± 0.19 | <0.05a |
(PRL) | ELISA | 3.06 ± 4.15 | 1.39 ± 1.34 | 0.71 ± 1.12 | 1.00 ± 0.50 | <0.05b |
RANTES | Array | 1.46 ± 0.29 | 1.32 ± 0.11 | 1.20 ± 0.25 | 1.00 ± 0.20 | <0.05a |
(CCL5) | ELISA | 1.13 ± 0.59 | 0.83 ±0.49 | 0.94 ± 0.32 | 1.00 ± 0.51 | nsb |